Jim Simons Renalytix PLC Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$1.06 - $2.21 $85,862 - $179,014
-81,002 Reduced 64.29%
45,000 $84,000
Q3 2022

Nov 14, 2022
BUY
$1.19 - $2.78 $149,942 - $350,285
126,002 New
126,002 $161,000
Q3 2021

Nov 12, 2021
SELL
$17.91 - $34.78 $146,862 - $285,196
-8,200 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$23.56 - $34.25 $193,192 - $280,850
8,200 New
8,200 $253,000

Others Institutions Holding RNLX

# of Institutions
29
Shares Held
3.91M
Call Options Held
13.7K
Put Options Held
0
View Full List

About Renalytix plc

RNLX Quotes by TradingView
  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email